Oxular

Oxular has developed a novel drug/device combination treatment for vision-threatening retinal diseases. The company's innovative technology enables sustained drug release, improved drug delivery, and reduced side effects while enhancing treatment efficacy. Oxular’s products primarily target prevalent retinal conditions (e.g., diabetic macular edema) as well as rare and difficult-to-treat diseases (e.g., ocular cancer).